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Filaggrin is expressed in the outermost layers of the human epidermis;1 it plays a central role in skin 
barrier formation through its multiple functions from the pro-protein which has calcium-binding 
domains, to the filaggrin monomers which aggregate keratin filaments, and to its constituent amino 
acids which are released in the stratum corneum contributing to water retention, ultraviolet B 
absorption and acidification.2 Loss of function mutations in the gene encoding filaggrin (FLG) cause 
ichthyosis vulgaris3 and strongly predispose to eczema as a manifestation of skin barrier dysfunction.4 
Whilst FLG null mutations lead to a marked reduction in filaggrin in skin, factors that increase the 
thickness of the stratum corneum may be considered to increase filaggrin expression in a specific or 
a non-specific way. Whilst filaggrin is intimately associated with cornification, it is interesting to note 
that FLG is still expressed in the non-keratinised areas of buccal mucosa.5  
Lichen planus (LP) is an inflammatory disease of unknown aetiology. The increased expression of 
keratins 1, 2, 10 and 11, along with a reduction in expression of keratins 4 and 13 have been reported 
in buccal mucosal LP.6 It has been proposed that barrier impairment may be a preceding event in the 
pathogenesis of LP, or it may occur as a secondary effect resulting from disturbance in keratinocyte 
differentiation.7 Opposing hypotheses can therefore be proposed: that filaggrin expression is either 
increased or decreased within the lesional epidermis in LP.  
The study by Larsen et al. reported in this edition of the JEADV8 set out to test several hypotheses 
relating to the relationship between oral lichenoid lesions (OLL, including oral LP), filaggrin 
expression, FLG mutations and co-associated skin conditions. 38 patients with OLL (including 19 with 
oral LP) and 11 with non-specific stomatitis were compared with 29 unaffected controls. 
Immunoflourescent staining of buccal mucosal biopsy specimens showed a marked increase in 
filaggrin expression in 21% of patients with OLL but none of the healthy controls; conversely there 
was a marked reduction in filaggrin immunostaining observed in 15% of healthy controls compared 
with 6% of patients with OLL. The differences in filaggrin staining showed no association with the 
presence or absence of loss of function mutations in FLG. The patients with OLL also did not have an 
increased prevalence of dermatological disorders (other than LP) when compared with controls. 
These findings must be interpreted with caution because of the small sample size. However, the 
observation of an increase in filaggrin expression in OLL that is independent of FLG genotype and 
unrelated to other skin disorders implies that the increased filaggrin expression is a secondary effect 
of local inflammation and hyperkeratosis rather than a primary aetiological factor. Filaggrin binds to 
keratins 2 and 10 and may therefore be increased in consort with them.6 The absence of association 
of LP with filaggrin down-regulation sheds doubt on the hypothesis that skin barrier dysfunction 
contributes to the primary pathogenesis of lichenoid inflammation; the underlying aetiology of oral 
LP continues to be enigmatic.  
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